Big Bucks Being Made on Cancer Pain
The New York Times brings us another example of how those drug companies that the president loves so much are ripping off the elderly.N.Y. Times
:
On Feb. 3, Joyce Elkins filled a prescription for a two-week supply of nitrogen mustard, a decades-old cancer drug used to treat a rare form of lymphoma. The cost was $77.50.
On Feb. 17, Ms. Elkins, a 64-year-old retiree who lives in Georgetown, Tex., returned to her pharmacy for a refill. This time, following a huge increase in the wholesale price of the drug, the cost was $548.01.
Ms. Elkins’s insurance does not cover nitrogen mustard, which she must take for at least the next six months at a cost that will now total nearly $7,000. She and her husband, who works for the Texas Department of Transportation, are paying for the medicine by spending less on utilities and food, she said.
Your support matters…Independent journalism is under threat and overshadowed by heavily funded mainstream media.
You can help level the playing field. Become a member.
Your tax-deductible contribution keeps us digging beneath the headlines to give you thought-provoking, investigative reporting and analysis that unearths what's really happening- without compromise.
Give today to support our courageous, independent journalists.
Global Voices
When “forever chemicals” contaminated their water, Italian mothers got organized and took the polluters to court.
Health & Wellness
Chevron intends to produce “climate-friendly” fuel in the Magnolia State and cancer-wary locals are concerned.
TD Original
Glyphosate is linked to the decline of honey bees and everything from cancer, autism and irritable bowel syndrome in humans.
Environment
Experts say the Inflation Reduction Act's push for biogas is "one step forward and two steps back."
The conservative commentator, who just announced he has advanced lung cancer, is presented with the honor during Trump's State of the Union.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.